Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Kang YK, Kim HD, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Cheong JH, Jeong O, Heo MH, Kim HK, Park C, Yoo CH, Kang SY, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Hwang JE, Ryu SW, Kook MC, Ryoo BY, Kim H, Yoo MW, Lee NS, Lee SH, Noh SH. Kang YK, et al. Among authors: heo mh. J Clin Oncol. 2024 Sep 1;42(25):2961-2965. doi: 10.1200/JCO.23.02167. Epub 2024 Jul 12. J Clin Oncol. 2024. PMID: 38996201 Clinical Trial.
Metachronous double primary cancer after diagnosis of gastric cancer.
Kim JY, Jang WY, Heo MH, Lee KK, Do YR, Park KU, Song HS, Kim YN. Kim JY, et al. Among authors: heo mh. Cancer Res Treat. 2012 Sep;44(3):173-8. doi: 10.4143/crt.2012.44.3.173. Epub 2012 Sep 30. Cancer Res Treat. 2012. PMID: 23091443 Free PMC article.
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.
Park S, Kang BW, Lee SJ, Yoon S, Chae YS, Kim JG, Lee KH, Koh SA, Song HS, Park KU, Kim JY, Heo MH, Ryoo HM, Cho YY, Jo J, Lee JL, Lee SA. Park S, et al. Among authors: heo mh. Cancer Chemother Pharmacol. 2017 Jul;80(1):187-193. doi: 10.1007/s00280-017-3348-z. Epub 2017 Jun 8. Cancer Chemother Pharmacol. 2017. PMID: 28597039
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Son T, Jung MR, Heo MH, Kim HK, Park C, Yoo CH, Choi JH, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Cho SH, Ryu SW, Kook MC, Ryoo BY, Kim HK, Yoo MW, Lee NS, Lee SH, Kim G, Lee Y, Lee JH, Noh SH. Kang YK, et al. Among authors: heo mh. J Clin Oncol. 2021 Sep 10;39(26):2903-2913. doi: 10.1200/JCO.20.02914. Epub 2021 Jun 16. J Clin Oncol. 2021. PMID: 34133211 Free PMC article. Clinical Trial.
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study.
Kim HD, Lee JS, Park YS, Yook JH, Noh SH, Park YK, Kim YW, Oh SC, Kim JG, Ryu MH, Cheong JH, Kim H, Lim JS, Lee JH, Heo SH, Kim JY, Heo MH, Park YI, Kim IH, Kang YK. Kim HD, et al. Among authors: heo mh, heo sh. Gastric Cancer. 2022 Nov;25(6):1039-1049. doi: 10.1007/s10120-022-01325-6. Epub 2022 Aug 3. Gastric Cancer. 2022. PMID: 35920999
52 results